UHT

Robert F. McCadden

Known title: DirectorCIK: 0001290896

Robert F. McCadden's purchase track record

How the stock did after each of Robert F. McCadden's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
3
of 3 since May 10, 2022
Stock higher 6 months later
67%
3 months: 100%
Median 6-month return
+3.7%
3 months: +13.8%
Beat the S&P 500
67%
median +1.8% vs. index
PurchaseStockAmount3 months6 months
5/9/2024UHT$75K+14.4%+16.3%
3/10/2023UHT$48K+4.0%-4.4%
5/10/2022UHT$120K+13.8%+3.7%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

UHT Dividend Analysis Highlights 7.28% Yield. Recent analysis focused on the dividend profile of Universal Health Realty Income Trust. The stock currently offers a yield of 7.28%, which is a key factor for income-focused investors. This metric stands out against the company's trailing P/E ratio of 27.7. The commentary serves as a reminder of the income aspect of the REIT.

this person other insiders at UHT

Transaction History

UHT▲ Buy$0
UHT▲ Buy$0
UHT▲ Buy$0
UHT▲ Buy$75K
UHT▲ Buy$0
UHT▲ Buy$48K
UHT▲ Buy$0
UHT▲ Buy$24K
UHT▲ Buy$96K

We use analytics to understand how market-wall is used. No personal data is sold.